Expression of Cyclooxygenase-2 in Human Transitional Cell Carcinoma of the Urinary Bladder
- 1 March 2001
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 158 (3) , 849-853
- https://doi.org/10.1016/s0002-9440(10)64033-3
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.2000
- Enhanced Expression of Cyclooxygenase-2 in High Grade Human Transitional Cell Bladder CarcinomasThe American Journal of Pathology, 2000
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder.2000
- High Cyclooxygenase-2 Expression in Stage IB Cervical Cancer with Lymph Node Metastasis or Parametrial InvasionGynecologic Oncology, 2000
- Localization of Cyclooxygenase-2 in Human Sporadic Colorectal AdenomasThe American Journal of Pathology, 2000
- Potential utility of COX-2 inhibitors in chemoprevention and chemotherapyExpert Opinion on Investigational Drugs, 1999
- Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasmsMolecular Carcinogenesis, 1999
- The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary BladderThe American Journal of Surgical Pathology, 1998
- The role of nonsteroidal anti-inflammatory drugs in colorectal cancer preventionEuropean Journal Of Cancer, 1995